ImmunityBio Inc. Common Stock vs Lattice Semiconductor Corporation Common Stock — how do they compare? ImmunityBio Inc. Common Stock trades at $10.02 (market cap $10.33B), while Lattice Semiconductor Corporation Common Stock trades at $125.42 (market cap $18.61B). The key difference: Lattice Semiconductor Corporation Common Stock is the larger of the two by market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, Lattice Semiconductor Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Lattice Semiconductor Corporation Common Stock for 0 Days on average.
| IBRX | LSCC | |
|---|---|---|
Market Cap | $10.33B | $18.61B |
Volume | 11,745,198 | 1,778,419 |
Sector | Health | Technology |
52-Week High | $11.55 | $155.27 |
52-Week Low | $1.98 | $61.73 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.79B | $18.48B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →Lattice Semiconductor develops low-power programmable chips, known as FPGAs. Its products are used in communications, computing, industrial, and automotive applications.
Read more on LSCC →